심부전의 약물 치료
Pharmacological Treatment of Heart Failure
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
수축기 심부전 환자에서 입증된 약제를 사용하는 것은 선택이 아니라 필수적인 사항이며 장기간 임상 연구로 입증된 약물을 환자 상태 Figure 1. Drug treatment algorithm of patients with heart failure [3,4]. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; Aldo Ant, aldosterone antagonist. 에 맞게 치료하는 것은 증상의 개선뿐만 아니라 장기 예후를 개선시키므로 이를 실제 임상에 맞게 적용하는 것은 중요하다.
Abstract
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In according to recommendation for treatment from major guideline, most patients with HF should be routinely managed with a combination of 3 types of drugs: a diuretic, an ACEI or an ARB, and a beta blocker. The value of these drugs has been established by the results of numerous large-scale clinical trials, and the evidence supporting a central role for their use is compelling. This review is focused on the drug treatment based on the evidence and practical implication. (Korean J Med 2011;81:716-719)
참고문헌 (5)
- McKee PA, "The natural history of congestive heart failure: the Framingham Study", N Engl J Med, 285, pp.1441~1446 (1971)
- Lindenfeld J, "HFSA 2010 comprehensive heart failure practice guideline", J Card Fail, 16, pp.e1~e194 (2010)
- Hunt SA, "2009 focused update incorporated into the ACC", AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation, Circulation, pp.2009, 119[DOI]
- Nieminen MS, "Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology", Eur Heart J, 26, pp.384~416 (2005)
- Owan TE, "Trends in prevalence and outcome of heart failure with preserved ejection fraction", N Engl J Med, 355, pp.251~259 (2006)